Reunion Neuroscience Funding: $233M Raised, Series A (2025)
Reunion Neuroscience is based in Mendham, New Jersey. It has raised $233M in total funding. Latest round: Series A.
Reunion Neuroscience funding overview
Reunion Neuroscience is based in Mendham, New Jersey. Reunion Neuroscience has raised $233M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in September 2025. The round record for Reunion Neuroscience runs through 2025; nothing later has been disclosed. Investors on record include MPM BioImpact, Novo Holdings, General Catalyst, MPM Capital, Arkin BIO Ventures, Femhealth Ventures and 5 others. 11 distinct backers are named across the disclosed rounds.
Reunion Neuroscience at a glance
Total raised
$233M
Latest round
Series A
Latest round date
September 2025
Headquarters
Mendham, New Jersey
Notable investors
MPM BioImpact, Novo Holdings, General Catalyst, MPM Capital, Arkin BIO Ventures, Femhealth Ventures, Mitsui & CO. Global Investment, Palo Santo
Frequently asked about Reunion Neuroscience funding
How much has Reunion Neuroscience raised?
Reunion Neuroscience has raised $233M in total disclosed funding across the rounds on record.
Who has invested in Reunion Neuroscience?
MPM BioImpact, Novo Holdings, General Catalyst, MPM Capital, Arkin BIO Ventures, Femhealth Ventures are named among the investors backing Reunion Neuroscience.
What was the latest Reunion Neuroscience funding round?
The most recent disclosed round is a Series A, announced in September 2025.
Where is Reunion Neuroscience based?
Reunion Neuroscience is based in Mendham, New Jersey.
When did Reunion Neuroscience last raise?
The last disclosed Reunion Neuroscience round closed in September 2025 at Series A.
Round data for Reunion Neuroscience is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Mendham and backer lists below.
